FDA Inspection
Fresenius Kabi ABFresenius Kabi AB – FDA Inspection, Oct 16, 2018
Record Details
This FDA Inspection record concerns Fresenius Kabi AB, with an inspection on October 16, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
- Person
- MRA DavisM (Issuing Officer)
View Company Profile
ID · 601d4a6e-431f-4514-affd-3f8945416a3c
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1099421
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Fresenius Kabi AB
7| Date | Classification | Office | Project area |
|---|---|---|---|
| April 21, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 15, 2020 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 7, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 20, 2015 | VAI | Center for Devices and Radiological Health | Bioresearch Monitoring |
| April 11, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Fresenius Kabi AB
- FDA Inspection 1238177 - 2023-04-21
- FDA Inspection 1155467 - 2020-10-15
- FDA Inspection 1005000 - 2017-02-07
- FDA Inspection 925969 - 2015-03-20
- FDA Inspection 876533 - 2014-04-11
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.